Try "researchers"
HomePsychedelicsPsychedelics for Mental Health
PsychedelicsResources

Psychedelics for Mental Health

Sheba Karamat
By Sheba Karamat
In this episode, Andrew’s guest is Robin Carhart-Harris, PhD, distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of leading researchers in the study of how psychedelics such as psilocybin, LSD and DMT can change the human brain and in doing so, be used to successfully treat various mental health challenges such as major depression, anorexia, obsessive-compulsive disorder (OCD) and addiction. He explains how psilocybin induces sustained changes in adaptive brain wiring and cognition
Previous article
Drug testing pilot extended to all summer Irish festivals
Next article
Thailand may restrict cannabis under draft proposal
Sheba Karamat
Sheba Karamat
RELATED ARTICLES

Related Articles

Load more

The Natural Halo reports on the latest industry news, research and thought leadership on cannabis, psilocybin, ibogaine and other psychedelic substances, and the reported benefits of using natural medicines. The growing science and evidence-based research highlights the therapeutic potential of cannabis and psychoactive products to treat severe depression, PTSD, drug dependency, end-of-life care and various other disorders and addictions. As many countries begin legalising the use of cannabis and psychoactive treatments, we are driving the agenda for safe cannabis and psychedelic therapies to become regulated, legalised and widely available treatments accepted fairly in society.

Contact

© Newspaper WordPress Theme by TagDiv